Fri.Aug 23, 2024

article thumbnail

Opinion: Why you may not need a checkup every year

STAT

I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.

362
362
article thumbnail

Association for Medical Education in Europe AMEE 2024 conference

Pharma Times

The conference will be held in Basel, Switzerland from 26-28 August

Hospitals 140
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: AI in medicine: A national registry could help increase transparency, experts say

STAT

The use of artificial intelligence in hospitals is ramping up so fast — and with such little transparency — that it is impossible to track how any given product is impacting the cost or quality of care. Whether AI is monitored at all is entirely up to individual health systems.   “Everybody is doing this differently, and many health systems are not doing it,” said Mike Pencina, chief data scientist at Duke Health.

Hospitals 343
article thumbnail

MHRA approves Astellas’ Vyloy combination for gastric cancer

Pharma Times

Most cases go undetected until an advanced stage, as the disease rarely causes early symptoms

136
136
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

STAT+: Tome Biosciences files notice to lay off virtually entire staff

STAT

High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire staff beginning Nov. 1. The Massachusetts WARN notice comes a day after STAT reported the company was in dire straits, with one source saying that it planned to wind down operations and seek a buyer by Nov. 1 after the company struggled to raise money or find a partner.

318
318

More Trending

article thumbnail

Opinion: A harm-reduction approach to eating out

STAT

Several years ago, while on a road trip, I ordered the now-discontinued spaghetti and meatballs during a pitstop at Denny’s. When the plate came out, I thought there was no way I could finish the massive platter, but then I did because it was right in front of me — even though I knew exactly what was going on. As an assistant professor of health policy, I examine the food environment and how we can encourage healthier choices.

Packaging 311
article thumbnail

Engage with pharmacy teams on major conditions, leaders urge government

The Pharmacist

Pharmacy leaders have urged the government to engage with pharmacy teams, as it appears to be reviewing its work to tackle major conditions. Earlier this month, public health minister Andrew Gwynne confirmed that work the government's major conditions strategy had been paused, saying: 'As we develop our plans to rebuild the NHS, we will consider […] The post Engage with pharmacy teams on major conditions, leaders urge government appeared first on The Pharmacist.

Diabetes 115
article thumbnail

Settlement blocks diagnostics maker EpicGenetics from selling two questionable blood tests

STAT

A diagnostics company has agreed to stop selling two questionable blood tests as part of a settlement with a consumer watchdog that accused the firm of using “false and misleading advertising” to promote the products.  Not only was EpicGenetics claiming that one of its blood tests could definitively diagnose fibromyalgia, the Center for Science in the Public Interest’s October 2023 lawsuit said; the company had also invented a disease wholesale to justify the use of ano

302
302
article thumbnail

Power to the patients: Patient organisations enabling drug development

pharmaphorum

Discover how patient organizations play a key role in enabling drug development with the support of EFPIA. Learn more about their involvement and impact in the pharmaceutical industry.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: U.S. agency slaps down a J&J plan to switch payments for 340B hospitals

STAT

A U.S. government agency said that a planned move by Johnson & Johnson to alter payment methods for some hospitals participating in a controversial drug discount program was “inconsistent” with federal law and requires approval before the company can proceed. The statement by the U.S. Health Resources and Services Administration came in response to a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices.

Hospitals 289
article thumbnail

AstraZeneca dismisses rumours of facility relocation to US

pharmaphorum

AstraZeneca says rumours that it will relocate a planned vaccines facility from the UK to the US "do not seem to be based on facts"

Vaccines 110
article thumbnail

STAT+: Pharmalittle: We’re reading about AstraZeneca threatening the U.K., mpox vaccine distribution, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still on the drawing board, but we do plan to catch up on our reading and napping, promenade with the official mascots, and hold another listening party with Mrs. Pharmalot, and the rotation will likely include this , this , this , this and this.

Vaccines 251
article thumbnail

Dr Reddy’s Glycemic Happiness Awareness initiative sets Guinness World Record

Express Pharma

Dr Reddy’s Laboratories has set a new Guinness World Record for building the largest brochure mosaic (logo) installation. This installation is part of its glycemic happiness awareness initiative for patients with Type 2 diabetes mellitus. The largest installation that entered the Guinness World Record stands at 162 square metres and consists of feedback from healthcare professionals across India on the ‘Glycemic Happiness Scale’.

Diabetes 110
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

145
145
article thumbnail

Versant, Novartis team up again in hunt for another Chinook

pharmaphorum

Novartis and VC Versant set up a new biotech, Borealis Biosciences, using a similar model to an earlier alliance to create Chinook Therapeutics

110
110
article thumbnail

Lupin gains Health Canada approval for biosimilar Pegfilgrastim

Express Pharma

Lupin announced that it has received approval from Health Canada for its biosimilar Pegfilgrastim. This product will be marketed under the brand name Armlupeg and manufactured at Lupin’s Biotech facility in Pune, India. Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim. Pegfilgrastim prefilled syringes are indicated to decrease the incidence of infection, as manifested by febrile neutropenia in patients with non-myeloid m

article thumbnail

US immunology biotech Zenas BioPharma files $100m IPO

pharmaphorum

Zenas BioPharma has filed an initial public offering in the US seeking $100m+ for obexelimab, a therapy for rare disease IgG4-RD in phase 3

105
105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Sun Pharma introduces STARIZO (Tedizolid Phosphate) in India for ABSSSI

Express Pharma

Sun Pharma has launched Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI). Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India.

Diabetes 105
article thumbnail

Pharma Pulse 8/23/24: Pfizer/BioNTech FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine, Hidden Obstacles in the Script-to-Therapy Journey & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Vaccines 105
article thumbnail

ICER says Geron's just-approved Rytelo is too pricey

pharmaphorum

ICER says Geron's new drug Rytelo for myelodysplastic syndromes (MDS) is priced three to four times higher than it should be

105
105
article thumbnail

EMCrit 382 – A Deep Dive on Vasopressin: Timing, Push Dose Vaso and the Vasopressin Load Test

EMCrit Project

A deep dive into vasopressin EMCrit Project by Scott Weingart, MD FCCM.

102
102
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

New COVID-19 jabs approved by FDA for 2024-25 season

pharmaphorum

The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent months.Both new mRNA-based vaccines have been approved for use in people aged 12 and over – and been granted emergency use authorisation for younger people aged 6 months to 11 years – and will be available within the next few days, said the drugmakers.

Vaccines 105
article thumbnail

Govt bans 156 FDCs with immediate effect

Express Pharma

The Ministry of Health and Family Welfare has banned 156 fixed-dose combinations (FDCs) medicines which include commonly used antibiotics, antiallergy medication, painkillers and multivitamins. The decision comes following an expert group appointed by the central government and recommendations by the Drug Technical Advisory Board (DTAB). The gazette notification stated, “The said Expert Committee considered this FDC as irrational.

98
article thumbnail

Tech & Trials: What’s all this about AI, then?

pharmaphorum

Learn about the fascinating world of artificial intelligence (AI) and machine learning in this informative article. Explore the concepts, applications, and impact of AI in various industries.

97
article thumbnail

Eli Lilly doubles down on Oblique partnership for antibody generation

Pharmaceutical Technology

The two companies have expanded their agreement first inked in 2023, with a second ‘high-value target’ now in the crosshairs.

96
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.